About This Stock More About This StockReadReadReadRead
Article By: Lorimer Wilson
Monday, March 27, 2017 4:57 PM EDT
Allergan’s partnership with Paratek is part of an ambitious effort to buy or partner up on a long range of experimental therapies for each of its core focus areas. The Botox maker has made a big investment in aesthetics and dermatology.
Article By: Marvin R Clark
Tuesday, February 14, 2017 11:31 PM EDT
Federal Reserve Chair Janet Yellen said the labor market is basically where the Fed wants it to be, and inflation is just a little lower than their target.
In this article: AET, AGN, CI, CS, FCX, GM, HUM, T, VZ, TOSBF, CYNO, HOLX, ZLTQ, TMUS, ANTM, QSR, PLKI, LITE
Article By: Jacob Maslow
Tuesday, February 14, 2017 6:39 AM EDT
Allergan announced on Monday that the company will acquire Zeltiq Aesthetics in a $2.48 billion deal. The company's failed merger with Pfizer Inc. last year has led to Allergen Chief Executive Brent Saunders acquiring several companies.